Skip to content

   Pharma Publications

Neuropsychopharmacology
  • A preliminary study of the effects of an antimuscarinic agent on anxious behaviors and white matter microarchitecture in nonhuman primates
    Published on 2023-07-29
    2 years ago
  • A unique role for cAMP signaling in microglia during opioid tolerance and withdrawal
    Published on 2023-07-28
    2 years ago
  • Effect of selective serotonin reuptake inhibitor treatment following diagnosis of depression on suicidal behaviour risk: a target trial emulation
    Published on 2023-07-28
    2 years ago
  • Correction: Ethical considerations in rapid and novel treatments in psychiatry
    Published on 2023-07-28
    2 years ago
  • Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl
    Published on 2023-07-27
    2 years ago
  • Kynurenic acid: translational perspectives of a therapeutically targetable gliotransmitter
    Published on 2023-07-27
    2 years ago
  • Control of dopamine communication by opioids: glutamate enters the discussion
    Published on 2023-07-27
    2 years ago
« Previous 1 … 88 89 90 91 92 … 143 Next »
Journal of Psychopharmacology
  • Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis
    Published on 2021-02-03
    5 years ago
  • Beyond the ‘purple drank’: Study of promethazine abuse according to the European Medicines Agency adverse drug reaction reports
    Published on 2021-01-11
    5 years ago
  • Does variation in trait schizotypy and frequency of cannabis use influence the acute subjective, cognitive and psychotomimetic effects of delta-9-tetrahydrocannabinol? A mega-analysis
    Published on 2021-01-09
    5 years ago
  • Cannabidiol prevents priming- and stress-induced reinstatement of the conditioned place preference induced by cocaine in mice
    Published on 2021-01-09
    5 years ago
  • Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD
    Published on 2021-01-09
    5 years ago
  • Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity
    Published on 2021-01-09
    5 years ago
  • Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data
    Published on 2021-01-09
    5 years ago
« Previous 1 … 88 89 90 91 92 … 134 Next »
European Neuropsychopharmacology
  • Offspring studies: Predicting conversion to psychosis
    Published on 2021-06-20
    5 years ago
  • Drug development for Autism Spectrum Disorder (ASD): Progress, challenges, and future directions
    Published on 2021-06-20
    5 years ago
  • Rating, berating or overrating antidepressant efficacy? The case of the Hamilton depression rating scale
    Published on 2021-06-19
    5 years ago
  • Suicide in the COVID-19 pandemic: what we learnt and great expectations
    Published on 2021-06-16
    5 years ago
  • Route map for machine learning in psychiatry: Absence of bias, reproducibility, and utility
    Published on 2021-06-09
    5 years ago
  • Autoimmune encephalitis or autoimmune psychosis?
    Published on 2021-06-06
    5 years ago
  • Pharmacokinetic and pharmacodynamic interactions between daridorexant, a dual orexin receptor antagonist, and citalopram in healthy subjects
    Published on 2021-06-05
    5 years ago
« Previous 1 … 88 89 90 91 92 … 154 Next »

   Pharma Pub